These Are Not The Drugs You Are Looking For.

Don’t Use Remdesivir. Just one month after the US Food and Drug Administration approved remdesivir as an antiviral for the treatment of patients with COVID-19, the WHO yesterday recommended that it not be used, on the basis that it is ineffective and there is “no evidence” it reduces mortality. Last month, we analysed remdesivir’s use […]

Read More…


Monetising A Vaccine Shows What It’s Really All About.

LOADSAMONEY! According to the sales pitch on Thursday from investment banks Credit Suisse and Morgan Stanley, a COVID-19 vaccine could be a “bumper revenue opportunity“, projected to earn at least $10 billion a year. Morgan Stanley’s projection is at least $10 billion a year across developed countries but Credit Suisse is bigging it up further […]

Read More…


Antivirals – lessons from the ‘flu jab’.

That Time Of Year Again. If you have read the previous two articles then you will know the main differences between a vaccine and an antiviral, and why Remdesivir is not an effective antiviral for just about anyone with COVID-19. We have highlighted that antivirals have a pretty patchy record when it comes to their […]

Read More…